Please assess the completion status of the following clinical trial:

Trial Title: Randomized Study for the Optimal Treatment of Symptomatic Patients With Low Gradient Severe Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \>18 years~2. Symptomatic and severe AS defined by an effective AVA ≤1 cm² and indexed AVA ≤0.6 cm2/m2~3. LVEF ≥50%~4. MAG \<40 mm Hg (measure confirmed by the multi-window continuous-wave Doppler interrogation and use of Pedoff probe)~5. Confirmation of the presence of severe AS at DSE and MDCT aortic calcium score~6. Feasibility of AVR by surgery or TAVR according to the heart team~7. Signature of an informed consent~Exclusion Criteria:~1. Uncontrolled atrial of ventricular arrhythmias~2. Patient having a life expectancy \<1 year, independently from their aortic pathology~3. Coronary artery disease necessitating a percutaneous or surgical revascularisation~4. Presence of a concomitant valve disease needing surgical treatment~5. Patient who are included in another research protocol~6. Protected person (adults legally protected (under judicial protection, guardianship or supervision), person deprived of their liberty, pregnant woman, lactating woman and minor)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- aortic valve replacement (Type: EXPERIMENTAL): None
- strict clinical surveillance (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).